Table 3. COSMIC identified SNV from matched tumor samples derived from blood or biopsy.
| ID | E/P/H | ctcDNA | ccfDNA | FFPE 1 | FFPE 2 |
|---|---|---|---|---|---|
| C293-001 | +/+/− | X | X | X | |
| C293-002 | −/−/+ | TP53; p.E285K | X | QNS tissue | |
| C293-003 | −/−/+ | X | X | X | |
| C293-004 | +/−/− | X | PIK3CA;p.E542K | PIK3CA;p.E542K | PIK3CA;p.E542K |
| C293-005 | +/−/+ | X | PIK3CA; p.V344G ERBB2; p.V777L |
PIK3CA; p.V344G ERBB2; p.V777L |
|
| C293-006 | −/−/− | X | TP53;p.H193R | TP53;p.H193R | |
| C293-007 | −/−/− | X | X | KRAS; V14I | |
| C293-008 | NA | X | TP53; p.S215R | QNS tissue | |
| C293-009 | +/+/Eq | X | X | X | |
| C293-010 | +/−/+ | TP53; p.Y163D | TP53; p.Y163D | QNS Tissue | |
| C293-011 | −/−/− | X | TP53; p.R175H | TP53; p.R175H | |
| C293-012 | +/−/− | X | X | X | |
| C293-013 | +/+/− | X | QNS DNA | PIK3CA; p.H1047R | X |
| C293-014 | +/+/Eq | X | TP53; p.M246I | X | |
| C293-015 | −/−/− | X | X | X | |
| C293-016 | −/−/+ | PIK3CA; p.E545K | X | QNS Tissue | |
| C293-018 | +/−/− | PIK3CA; p.H1047R | PIK3CA; p.H1047R | QNS DNA | PIK3CA; p.H1047R |
| C293-019 | +/+/− | X | X | IDH2; p.R140Q | |
| C293-020 | −/−/− | X | X | X | |
| C293-021 | +/+/− | X | GNAQ; Q209K | X | |
| C293-022 | +/+/− | X | X | PIK3CA; p.E545K | |
| C293-023 | −/+/Eq | TP53; p.R175H | TP53; p.R175H | TP53; p.R175H | |
| C293-024 | +/−/− | X | PIK3CA; p.H1047R | X | PIK3CA; p.H1047R |
| C293-025 | +/−/− | X | X | X | |
| C293-026 | +/−/Eq | PIK3CA; p.H1047R | PIK3CA; p.H1047R | TP53; p.C182Y | APC; p.Q1447* TP53; p.G108S PIK3CA; p.H1047R |
| C293-027 | +/+/− | TP53; p.H178P | X | X | |
| C293-028 | +/−/− | X | X | QNS DNA | |
| C293-029 | −/−/+ | X | TP53; p.E286K | QNS DNA | |
| C293-030 | +/+/− | X | X | ERBB2; V777L | |
| C293-031 | +/+/− | X | X | X | |
| C293-032 | −/−/− | X | TP53; p.Y107* | X | |
| C293-033 | +/+/− | TP53; p.C176F | TP53; p.C176F TP53; p.C176S |
TP53; p.C176F |
Most recent hormonal (ER/PR) and Her2 status is included where available (E/P/H) and indicated as present (+), absent (-), or equivocal (Eq). Alterations are indicated by the target gene and the predicted impact. Samples with no detectable alteration at the limit of detection are indicated by X. Samples that were quantity not sufficient (QNS) are indicated.